SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-6 POS - Post-effective amendments for immediately effective filing:
SEC Accession No. 0001161697-22-000516
Filing Date
2022-10-21
Accepted
2022-10-21 17:28:10
Documents
5

Document Format Files

Seq Description Document Type Size
1 FORM F-6 POST EFFECTIVE AMENDMENT NO. 2 TO REGISTRATION STATEMENT f-6.htm F-6 POS 59834
2 EXHIBIT (A)(3) - FORM OF AMENDMENT NO. 2 TO THE DEPOSIT AGREEMENT ex_99a3.htm EX-99.(A)(3) 129054
3 GRAPHIC ex_99a3-1.jpg GRAPHIC 126551
4 GRAPHIC ex_99a3-2.jpg GRAPHIC 7225
5 EXHIBIT (E) - RULE 466 CERTIFICATION ex_99e.htm EX-99.(E) 3730
  Complete submission text file 0001161697-22-000516.txt   378804
Mailing Address 383 MADISON AVENUE 11TH FLOOR NEW YORK NY 10179
Business Address 383 MADISON AVENUE 11TH FLOOR NEW YORK NY 10179 212-319-7600
JPMorgan Chase Bank, N.A. - ADR Depositary (Filed by) CIK: 0001474274 (see all company filings)

IRS No.: 000000000 | State of Incorp.: OH | Fiscal Year End: 1231
Type: F-6 POS
SIC: 8880 American Depositary Receipts

Mailing Address AVENUE DE SECHERON 15 CH-1202 GENEVA V8 NA
Business Address AVENUE DE SECHERON 15 CH-1202 GENEVA V8 NA 914-672-3555
Relief Therapeutics Holding SA (Subject) CIK: 0001854078 (see all company filings)

IRS No.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: F-6 POS | Act: 33 | File No.: 333-260712 | Film No.: 221324468
SIC: 2834 Pharmaceutical Preparations